Organon & Co.
(NYSE: OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

7.140

-0.125 (-1.72%)
Range 7.120 - 7.305   (2.60%)
Open 7.285
Previous Close 7.265
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 3,169,351
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis